- Home
- GERN vs FBRT Comparison
GERN vs FBRT Comparison
Compare GERN & FBRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- FBRT
- Stock Information
- Founded
- GERN 1990
- FBRT 2012
- Country
- GERN United States
- FBRT United States
- Employees
- GERN N/A
- FBRT N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- FBRT Real Estate Investment Trusts
- Sector
- GERN Health Care
- FBRT Real Estate
- Exchange
- GERN Nasdaq
- FBRT Nasdaq
- Market Cap
- GERN 740.5M
- FBRT 882.8M
- IPO Year
- GERN 1996
- FBRT 1985
- Fundamental
- Price
- GERN $1.12
- FBRT $9.96
- Analyst Decision
- GERN Buy
- FBRT Strong Buy
- Analyst Count
- GERN 7
- FBRT 4
- Target Price
- GERN $3.00
- FBRT $14.75
- AVG Volume (30 Days)
- GERN 8.6M
- FBRT 779.8K
- Earning Date
- GERN 11-05-2025
- FBRT 10-29-2025
- Dividend Yield
- GERN N/A
- FBRT 14.20%
- EPS Growth
- GERN N/A
- FBRT N/A
- EPS
- GERN N/A
- FBRT 0.80
- Revenue
- GERN $183,403,000.00
- FBRT $241,051,000.00
- Revenue This Year
- GERN $166.20
- FBRT $24.35
- Revenue Next Year
- GERN $55.83
- FBRT $7.16
- P/E Ratio
- GERN N/A
- FBRT $12.52
- Revenue Growth
- GERN 522.13
- FBRT 32.77
- 52 Week Low
- GERN $1.04
- FBRT $9.78
- 52 Week High
- GERN $4.21
- FBRT $13.58
- Technical
- Relative Strength Index (RSI)
- GERN 40.96
- FBRT 34.90
- Support Level
- GERN $1.04
- FBRT $9.78
- Resistance Level
- GERN $1.28
- FBRT $10.20
- Average True Range (ATR)
- GERN 0.07
- FBRT 0.21
- MACD
- GERN 0.00
- FBRT -0.02
- Stochastic Oscillator
- GERN 30.12
- FBRT 16.67
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About FBRT Franklin BSP Realty Trust Inc.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. Its segments include the real estate debt business; the real estate securities business; the real estate owned business; and the commercial real estate conduit business.